Division of Bacterial Diseases (DBD) News Bulletin
This website is archived for historical purposes and is no longer being maintained or updated.
January 14, 2014: Content on this page kept for historical reasons.
In This Issue
DBD Labs Pass CLIA with Flying Colors
Earlier this summer, laboratories within the Division of Bacterial Diseases (DBD) passed an important inspection, demonstrating that they meet federal quality standards. All U.S. facilities and sites that test human specimens for health assessment or to diagnose, prevent, or treat disease—including many CDC laboratories—undergo this inspection as part of the Clinical Laboratory Improvement Amendments (CLIA) of 1988. Due to the extraordinary efforts of our labs, DBD passed the CLIA inspection with flying colors.
Preparing for CLIA inspection occurs year-round. DBD labs ensure that all their records, competency tests, proficiency tests, and other documents and tests, are continuously up to date. Preparation to become a CLIA-certified lab is a very rigorous, time-intensive and demanding process—but a necessary and important task. The emphasis placed on passing inspection cannot be overstated—if one lab at CDC fails the CLIA inspection, then all labs are affected and cannot work.
- Page last reviewed: January 14, 2014 (archived document)
- Content source: